CD79A and Recurrent upper respiratory tract infections: Bermon et al. [149] revealed that the course and severity of upper respiratory tract infection were decreased in the 20 high-level long-distance runners after the oral administration of Lactobacillus yeast, while the levels of IgA, IL-4 and IL-12 in saliva were not significantly changed.